1.Renal Interstitial Fibrosis and Renin Angiotensin System Inhibition.
Journal of the Korean Pediatric Society 2001;44(3):292-296
No abstract available.
Fibrosis*
;
Renin*
;
Renin-Angiotensin System*
2.Role of Renin Angiotensin System in Clitoral avernosum Smooth Muscle.
Seung Choi PARK ; Kyung Woo CHO ; Jong Kwan PARK
Korean Journal of Urology 2000;41(3):387-394
No abstract available.
Muscle, Smooth*
;
Renin*
;
Renin-Angiotensin System*
3.Renin-Angiotensin-Aldosterone System Blockade and Renal Protection in Diabetic Nephropathy.
Korean Journal of Nephrology 2005;24(5):687-690
No abstract available.
Diabetic Nephropathies*
;
Renin-Angiotensin System*
4.The role of renin-angiotensin system in the pathogenesis of diabetic nephropathy.
Hunjoo HA ; Ho Chul WOO ; Kyung Hwan KIM
Korean Journal of Nephrology 1992;11(2):89-100
No abstract available.
Diabetic Nephropathies*
;
Renin-Angiotensin System*
5.Renin Angiotensin System in Rabbit Corpus Cavernosum: Functional Characterization of Angiotensin II Receptors.
Jong Kwan PARK ; Young Kyung PARK ; Sung Zoo KIM ; Suhn Hee KIM ; Kyung Woo CHO
Korean Journal of Urology 1997;38(1):28-36
No abstract available.
Angiotensin I
;
Angiotensin II*
;
Angiotensins*
;
Autoradiography
;
Receptors, Angiotensin*
;
Renin*
;
Renin-Angiotensin System*
6.Renin Angiotensin System in Rabbit Corpus Cavernosum: Functional Characterization of Angiotensin II Receptors.
Jong Kwan PARK ; Young Kyung PARK ; Sung Zoo KIM ; Suhn Hee KIM ; Kyung Woo CHO
Korean Journal of Urology 1997;38(1):28-36
No abstract available.
Angiotensin I
;
Angiotensin II*
;
Angiotensins*
;
Autoradiography
;
Receptors, Angiotensin*
;
Renin*
;
Renin-Angiotensin System*
10.Effects of Cyclosporine on the Intrarenal Renin-Angiotensin System.
Jong Seong KIM ; Mi Ra AN ; Nam Ho KIM ; Ki Chul CHOI ; Jong Un LEE
Korean Journal of Nephrology 1998;17(5):679-685
The present study was aimed at investigating the effect of cyclosporine A (CsA) on the renal renin-angiotensin systems. In rats chronically treated with CsA, the intrarenal expression of various genes of the renin-angiotensin system was assessed by Northern blot analysis. Along with the increases in plasma and renal renin activities, chronic CsA-treatment differentially affected the renal expression of renin-angiotensin system. The treatment with CsA for one week did not significantly alter the expression of either type 1 angiotensin II receptor (AT1A) or angiotensinogen gene, but increased the renin mRNA level. The three-week-treatment caused increases in the expression not only of renin but also of AT1A and angiotensinogen genes. Supplementation with L-arginine kept the expression of renin mRNA normal in the one-week-treated, but failed to prevent the alterations of the gene expression in the three-week-treated. Feedback control among components of the renin-angiotensin system also influences angiotesinogen. In the liver, the expression of angiotensinogen mRNA was decreased by the CsA-treatment for either one- or three-weeks. In conclusion, chronic CsA-treatment is associated with a differential expression of various genes for the renin-angiotensin system. L-Arginine may be effective in maintaining the normality of renin-angiotensin system only during early period after beginning the use of CsA.
Angiotensinogen
;
Animals
;
Arginine
;
Blotting, Northern
;
Cyclosporine*
;
Gene Expression
;
Liver
;
Plasma
;
Rats
;
Receptors, Angiotensin
;
Renin
;
Renin-Angiotensin System*
;
RNA, Messenger